Vigilare Wealth Management Tg Therapeutics, Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$7.81 - $20.45 $297,834 - $779,860	-38,135 Closed	0 $0
Q4 2021 Jan 07, 2022	BUY	$15.2 - $35.51 $278,540 - $650,720	18,325 Added 92.5%	38,135 $725,000
Q3 2021 Oct 19, 2021	BUY	$21.78 - $40.45 $216,166 - $401,466	9,925 Added 100.4%	19,810 $659,000
Q2 2021 Jul 16, 2021	BUY	$32.5 - $48.96 $105,625 - $159,120	3,250 Added 48.98%	9,885 $383,000
Q1 2021 Apr 29, 2021	BUY	$41.61 - $54.3 $111,722 - $145,795	2,685 Added 67.97%	6,635 $320,000
Q4 2020 Jan 14, 2021	BUY	$25.27 - $54.9 $99,816 - $216,855	3,950 New	3,950 $205,000

288

91.8M

1.9M

1.45M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.25B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.